VICL

Vical Reports Third Quarter 2012 Financial Results and Progress in Key Development Programs

[at noodls] – SAN DIEGO, Nov. 7, 2012 (GLOBE NEWSWIRE) — Vical Incorporated (Nasdaq:VICL) today reported financial results for the three months and nine months ended September 30, 2012. Revenues were $2.2 million for … moreView todays social media effects on VICLView the latest stocks trending across Twitter. Click to view dashboard […]

Vical Names Mammen P. Mammen, Jr., M.D., Vice President, Clinical Vaccines

[at noodls] – SAN DIEGO, Nov. 2, 2012 (GLOBE NEWSWIRE) — Vical Incorporated (Nasdaq:VICL) today announced the appointment of Mammen P. Anza Mammen, Jr., M.D., as Vice President, Clinical Vaccines. Prior … moreView todays social media effects on VICLView the latest stocks trending across Twitter. Click to view dashboard […]

Vical Announces News Release and Conference Call Schedule for Third Quarter 2012 Financial Results

[at noodls] – SAN DIEGO, Oct. 31, 2012 (GLOBE NEWSWIRE) — Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three months and nine months ended September 30, 2012, … moreView todays social media effects on VICLView the latest stocks trending across Twitter. Click to view dashboard […]

Vical Appoints George J. Morrow to Board of Directors

[at noodls] – SAN DIEGO, Oct. 16, 2012 (GLOBE NEWSWIRE) — Vical Incorporated (Nasdaq:VICL) announced today that George J. Morrow, former Executive Vice President of Global Commercial Operations at Amgen, Inc., has … moreView todays social media effects on VICLView the latest stocks trending across Twitter. Click to view dashboard […]